Bioscience Investment Intern - Summer 2027

Connecticut Innovations (CI) CI is Connecticut's strategic venture capital arm and one of the most active early-stage investors on the eastern seaboard. CI has a portfolio of 250+ companies across 5 equity funds and a 1 venture debt fund. We have $550 million in assets under management, and our venture portfolio employs 4,000 jobs. In a typical year, we deploy $50 million and write between 60-80 checks. We review 750 companies per year and invite over 100 founders in to pitch us each year. We add 30 new companies to our portfolio annually, and we also invest as an LP in Connecticut-based venture capital funds. We measure success through both financial returns and economic impact, including job creation. Over the past decade, CI has generated more than $400 million in returns and cumulatively, our portfolio companies have raised over $8 billion. Fiscal 2026 was our best year on record. We generated $76.1 million in cash proceeds from all investment activities. Most of those proceeds came from our strong New Haven bioscience sector. In FY26 actuals, we invested $59.3 million into 75 early-stage companies and venture funds, and those deals pulled an additional $1.2 billion of outside capital into the state. As of July 2026, CI earned the #1 spot in New England for portfolio exit value and ranked among top 5 East Coast venture firms investing at the Series B stage or earlier. Over the past 365 days, CI generated more than $125 million in cash returns Our culture is vibrant, diverse, collaborative, and inclusive. We embrace perspective and have mission alignment on our impact to Connecticut's innovation ecosystem. Connecticut Bioscience Innovation Fund (CBIF) Through the $200 million CBIF , CI accelerates bioscience breakthroughs by providing equity investments and loans. The portfolio includes 100+ companies across digital health, biotech, pharma, diagnostics, life science tools, and medical devices. Since 2013, bioscience investments have more than doubled , leveraging $3.5+ billion in outside capital Recent IPOs: Arvinas, Biohaven Pharmaceuticals, RallyBio, Sema4 Recent acquisitions: Avitus, Biorez, DiA Imaging Analysis, Diameter Health, Populi Venture Team Internship Join CI's Venture Team to gain hands-on venture capital experience in a fast-paced, innovative environment. Interns contribute to projects that strengthen the venture infrastructure, support due diligence, and drive portfolio success. We seek MBA, PhD, MS, or MPH students passionate about venture capital—especially those with backgrounds in life sciences or healthcare —who are enrolled in or reside in Connecticut. The CBIF Venture Team is small in size, but each team member plays a pivotal role in investment due diligence and post-investment portfolio growth. The team values diverse perspectives, bold thinking, and mission alignment. Responsibilities Collect and analyze data on portfolio activity, industries, markets, and competitors Support investment monitoring, financial analysis, and market research Assist with due diligence, including business plan assessment and company evaluations Build financial models and prepare presentations for the CI Investment Committee Contribute to lead generation, sourcing, and business development activities Qualifications Current or recent MBA, PhD, MS, or MPH student Strong interest in venture capital and early-stage innovation Research or professional experience in life sciences or healthcare Based in or studying in Connecticut Available to work hybrid in New Haven Skills